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. . . men who drink more than 4 standard 
drinks in a day (or more than 14 per week) 
and women who drink more than 3 in a day 
(or more than 7 per week) are at increased risk 
for alcohol-related problems. 
INTRODUCTION 
Introduction 
This Guide is written for primary care and mental health clinicians. It has 
been produced by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), 
a component of the National Institutes of Health, with guidance from physicians, 
nurses, advanced practice nurses, physician assistants, and clinical researchers. 
How much is “too much”? 
Drinking becomes too much when it causes or elevates the risk for alcohol-related 
problems or complicates the management of other health problems. According to 
epidemiologic research, men who drink more than 4 standard drinks in a day (or 
more than 14 per week) and women who drink more than 3 in a day (or more 
than 7 per week) are at increased risk for alcohol-related problems.1 
Individual responses to alcohol vary, however. Drinking at lower levels may be 
problematic depending on many factors, such as age, coexisting conditions, and use 
of medication. Because it isn’t known whether any amount of alcohol is safe during 
pregnancy, the Surgeon General urges abstinence for women who are or may 
become pregnant.2 
Why screen for heavy drinking? 
At-risk drinking and alcohol problems are common. About 3 in 10 U.S. adults 
drink at levels that elevate their risk for physical, mental health, and social 
problems.3 Of these heavy drinkers, about 1 in 4 currently has alcohol abuse 
or dependence.3 All heavy drinkers have a greater risk of hypertension, gastro­
intestinal bleeding, sleep disorders, major depression, hemorrhagic stroke, cirrhosis 
of the liver, and several cancers.4 
Heavy drinking often goes undetected. In a recent study of primary care 
practices, for example, patients with alcohol dependence received the 
recommended quality of care, including assessment and referral to treatment, 
only about 10 percent of the time.5 
Patients are likely to be more receptive, open, and ready to change than 
you expect. Most patients don’t object to being screened for alcohol use by 
clinicians and are open to hearing advice afterward.6 In addition, most primary 
care patients who screen positive for heavy drinking or alcohol use disorders show 
some motivational readiness to change, with those who have the most severe 
symptoms being the most ready.7 
You’re in a prime position to make a difference. Clinical trials have 
demonstrated that brief interventions can promote significant, lasting reductions 
in drinking levels in at-risk drinkers who aren’t alcohol dependent.8 Some drinkers 
who are dependent will accept referral to addiction treatment programs. Even for 
patients who don’t accept a referral, repeated alcohol-focused visits with a health 
care provider can lead to significant improvement.9,10 
If you’re not already doing so, we encourage you to incorporate alcohol screening 
and intervention into your practice. With this Guide, you have what you need 
to begin. 
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WHAT’S THE SAME, WHAT’S NEW 
What’s the Same, What’s New in This Update  
Same approach to screening and intervention 
The approach to alcohol screening and intervention presented in the original 2005 Guide 
remains unchanged. That edition established a number of new directions compared with 
earlier versions, including a simplified, single-question screening question; more guidance for 
managing alcohol-dependent patients; and an expanded target audience that includes mental 
health practitioners, since their patients are more likely to have alcohol problems than 
patients in the general population.11,12 
In the “how-to” section, two small revisions are noteworthy. Feedback from Guide users told 
us that some patients do not consider beer to be an alcoholic beverage, so the prescreening 
question on page 4 now reads, “Do you sometimes drink beer, wine, or other alcoholic bever­
ages?” And on page 5, the assessment criteria remain the same, but the sequence now better 
reflects a likely progression of symptoms in alcohol use disorders. 
Updated and new supporting materials  
Updated medications section. The section on prescribing medications (pages 13–16) 
contains added information about treatment strategies and options. It describes a newly 
approved, extended-release injectable drug to treat alcohol dependence that joins three 
previously approved oral medications.  
Medication management support. Patients taking medications for alcohol dependence 
require some behavioral support, but this doesn’t need to be specialized alcohol 
counseling. For clinicians in general medicine and mental health settings, the Guide now 
outlines a brief, effective program of behavioral support that was developed for patients 
who received pharmacotherapy in a recent clinical trial (pages 17–22). 
Specialized alcohol counseling resource. For mental health clinicians who wish to 
provide specialized counseling for alcohol dependence, we’ve added information about a 
state-of-the-art behavioral intervention also developed for a recent clinical trial (page 31). 
Online resources. A new page on the NIAAA Web site is devoted to the Guide and 
related resources (www.niaaa.nih.gov/guide). See page 27 for a sampling of available forms, 
publications, and training resources. 
New patient education handout. “Strategies for Cutting Down” provides concise 
guidance for patients who are ready to cut back or quit. The handout may be photo­
copied from page 26 or downloaded from www.niaaa.nih.gov/guide, where it is also 
available in Spanish. 
Transferred sections. Two appendix resources from the preceding edition (the sample 
questions for assessment and the preformatted progress notes for baseline and followup 
visits) are now available online at www.niaaa.nih.gov/guide. The previous “Materials from 
NIAAA” section is now part of the “Online Materials for Clinicians and Patients” on 
page 27. 
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Before You Begin… 
Decide on a screening method 
The Guide provides two methods for screening: a single question (about heavy 
drinking days) to use during a clinical interview and a written self-report 
instrument (the AUDIT—see page 11). The single interview question can be 
used at any time, either in conjunction with the AUDIT or alone. Some 
practices may prefer to have patients fill out the AUDIT before they see the 
clinician. It takes less than 5 minutes to complete and can be copied or 
incorporated into a health history. 
Think about clinical indications for screening 
Key opportunities include  
As part of a routine examination 
Before prescribing a medication that interacts with alcohol (see box on 
page 29) 
In the emergency department or urgent care center 
When seeing patients who 
• are  pregnant or trying to conceive 
• are  likely to drink heavily, such as smokers, adolescents, and 

young adults

•	 have health problems that might be alcohol induced, such as

cardiac arrhythmia dyspepsia liver disease

depression or anxiety insomnia trauma

•	 have a chronic illness that isn’t responding to treatment as 
expected, such as 
chronic pain diabetes gastrointestinal disorders 
depression heart disease hypertension 
Set up your practice to simplify the process 
Decide who will conduct the screening (you, other clinical personnel, 
the receptionist who hands out the AUDIT) 
Use preformatted progress notes (see “Online Materials” on page 27) 
Use computer reminders (if using electronic medical records) 
Keep copies of the pocket guide (provided) and referral information in your 
examination rooms 
Monitor your performance through practice audits 
BEFORE YOU BEGIN . . . 
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HOW TO HELP PATIENTS: A CLINICAL APPROACH 
How to Help Patients Who Drink Too Much: A Clinical Approach

STEP 1 Ask About Alcohol Use

Prescreen: Do you sometimes drink beer, wine, or other alcoholic beverages? 
NO 
Screening complete. 
YES 
Is the screening positive? 
1 or more heavy drinking days or 
AUDIT score of ≥ 8 for men or 
≥ 4 for women 
Ask the screening question about 
heavy drinking days: 
How many times in the past year 
have you had . . . 
5 or more drinks in 4 or more drinks in 
a day? (for men) a day? (for women) 
One standard drink is equivalent to 12 ounces of beer, 5 ounces 
of wine, or 1.5 ounces of 80-proof spirits—see chart on page 24. 
If the patient used a written self-
report (such as the AUDIT, p. 11), 
START HERE 
NO 
Advise staying within these limits: 
Maximum Drinking Limits 
For healthy men up to age 65— 
• no more than 4 drinks in a day AND 
• no more than 14 drinks in a week 
For healthy women (and healthy men over 
age 65)— 
• no more than 3 drinks in a day AND 
• no more than 7 drinks in a week 
Recommend lower limits or abstinence as 
medically indicated: for example, for patients 
who 
• take medications that interact with alcohol 
• have a health condition exacerbated by 
alcohol 
•  are  pregnant (advise abstinence) 
Express openness to talking about alcohol use 
and any concerns it may raise 
Rescreen annually 
YES 
GO TO 
STEP 2 
Your patient is an at-risk drinker. For a more 
complete picture of the drinking pattern, 
determine the weekly average: 
• On average, how many days a 
week do you have an alcoholic 
drink? 
X 
• On a typical drinking day, how 
many drinks do you have? 
Weekly average 
Record heavy drinking days in the past year and 
the weekly average in the patient’s chart (see page 
27 for a downloadable baseline progress note). 
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HOW TO HELP PATIENTS: A CLINICAL APPROACH 
STEP 2 Assess for Alcohol Use Disorders

Next, determine whether there is a maladaptive pattern of alcohol use, causing clinically significant 
impairment or distress. It is important to assess the severity and extent of all alcohol-related symptoms 
to inform your decisions about management. The following list of symptoms is adapted from the 
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), Revised. Sample assessment 
questions are available online at www.niaaa.nih.gov/guide. 
Determine whether, in the past 12 months, your patient’s drinking has repeatedly caused or 
contributed to 
risk of bodily harm (drinking and driving, operating machinery, swimming) 
relationship trouble (family or friends) 
role failure (interference with home, work, or school obligations) 
run-ins with the law (arrests or other legal problems) 
If yes to one or more your patient has alcohol abuse. 
In either case, proceed to assess for dependence symptoms. 
Determine whether, in the past 12 months, your patient has 
not been able to stick to drinking limits (repeatedly gone over them) 
not been able to cut down or stop (repeated failed attempts) 
shown tolerance (needed to drink a lot more to get the same effect) 
shown signs of withdrawal (tremors, sweating, nausea, or insomnia when trying to quit or 
cut down) 
kept drinking despite problems (recurrent physical or psychological problems) 
spent a lot of time drinking (or anticipating or recovering from drinking) 
spent less time on other matters (activities that had been important or pleasurable) 
If yes to three or more your patient has alcohol dependence. 
Does the patient meet the criteria for alcohol abuse or dependence? 
NO 
Your patient is still 
at risk for developing 
alcohol-related problems 
GO TO 
STEPS 3 & 4 
for AT-RISK 
DRINKING, 
page 6 
YES 
Your patient has an 
alcohol use disorder 
GO TO 
STEPS 3 & 4 
for ALCOHOL USE 
DISORDERS, 
page 7 
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AT-RISK DRINKING (no abuse or dependence) 
HOW TO HELP PATIENTS: A CLINICAL APPROACH 
STEP 3 Advise and Assist (Brief Intervention)

Is the patient ready to commit to change at this time? 
State your conclusion and recommendation clearly: 
• “You’re drinking more than is medically safe.” Relate to the patient’s concerns and medical findings, if present. 
(Consider using the chart on page 25 to show increased risk.)  
• “I strongly recommend that you cut down (or quit) and I’m willling to help.” (See page 29 for advice considerations.)  
Gauge readiness to change drinking habits: 
“Are you willing to consider making changes in your drinking?” 
NO 
Don’t be discouraged—ambivalence is common. Your 
advice has likely prompted a change in your patient’s 
thinking, a positive change in itself. With continued 
reinforcement, your patient may decide to take action. 
For now, 
Restate your concern about his or her health. 
Encourage reflection by asking patients to weigh 
what they like about drinking versus their reasons 
for cutting down. What are the major barriers to 
change? 
Reaffirm your willingness to help when he 
or she is ready. 
YES 
Help set a goal to cut down to within maximum 
limits (see Step 1) or abstain for a time. 
Agree on a plan, including 
• what specific steps the patient will take 
(e.g., not go to a bar after work, measure 
all drinks at home, alternate alcoholic and 
nonalcoholic beverages). 
• how drinking will be tracked (diary, kitchen 
calendar). 
• how the patient will manage high-risk situations. 
• who might be willing to help, such as 
significant others or nondrinking friends. 
Provide educational materials. See page 26 for 
“Strategies for Cutting Down” and page 27 for 
other materials available from NIAAA. 

STEP 4 At Followup: Continue Support
REMINDER: Document alcohol use and review goals at each visit (see page 27 for downloadable progress notes). 
Was the patient able to meet and sustain the drinking goal? 
NO 
Acknowledge that change is difficult. 
Support any positive change and address 
barriers to reaching the goal. 
Renegotiate the goal and plan; consider a trial 
of abstinence. 
Consider engaging significant others. 
Reassess the diagnosis if the patient is unable 
to either cut down or abstain. (Go to Step 2.) 
YES 
Reinforce and support continued adherence 
to recommendations. 
Renegotiate drinking goals as indicated (e.g., if 
the medical condition changes or if an abstaining 
patient wishes to resume drinking). 
Encourage the patient to return if unable to 
maintain adherence. 
Rescreen at least annually. 
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ALCOHOL USE DISORDERS (abuse or dependence) 
STEP 3 Advise and Assist (Brief Intervention)

State your conclusion and recommendation clearly: 
•	 “I believe that you have an alcohol use disorder. I strongly recommend that you quit drinking and I’m willing to help.” 
•	 Relate to the patient’s concerns and medical findings if present. 
Negotiate a drinking goal: 
•	 Abstaining is the safest course for most patients with alcohol use disorders. 
•	 Patients who have milder forms of abuse or dependence and are unwilling to abstain may be successful at cutting down. 
(See Step 3 for At-Risk Drinking.) 
Consider referring for additional evaluation by an addiction specialist, especially if the patient is 
dependent. (See page 23 for tips on finding treatment resources.) 
Consider recommending a mutual help group. 
For patients who have dependence, consider 
•	 the need for medically managed withdrawal (detoxification) and treat accordingly (see page 31). 
• prescribing a medication for alcohol dependence for those who endorse abstinence as a goal (see page 13). 
Arrange followup appointments, including medication management support if needed (see page 17). 
STEP 4 At Followup: Continue Support

REMINDER: Document alcohol use and review goals at each visit (see page 27 for downloadable progress notes). 
If the patient is receiving a medication for alcohol dependence, medication management support should be provided 
(see page 17). 
Was the patient able to meet and sustain the drinking goal? 
NO 
Acknowledge that change is difficult. 
Support efforts to cut down or abstain, while 
making it clear that your recommendation is 
to abstain. 
Relate drinking to problems (medical, 
psychological, and social) as appropriate. 
If the following measures aren’t already being 
taken, consider 
• referring to an addiction specialist or 
consulting with one. 
• recommending a mutual help group. 
• engaging significant others. 
• prescribing a medication for alcohol-
dependent patients who endorse 
abstinence as a goal. 
Address coexisting disorders—medical and 
psychiatric—as needed. 
YES 
Reinforce and support continued adherence 
to recommendations. 
Coordinate care with a specialist if the patient 
has accepted referral. 
Maintain medications for alcohol dependence 
for at least 3 months and as clinically indicated 
thereafter. 
Treat coexisting nicotine dependence for 6 to 
12 months after reaching the drinking goal. 
Address coexisting disorders—medical and 
psychiatric—as needed. 
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CLINICIAN SUPPORT MATERIALS 
Screening Instrument: The Alcohol Use Disorders 
Identification Test (AUDIT) 
Your practice may choose to have patients fill out a written screening 
instrument before they see a clinician. In this Guide, the AUDIT is provided in 
both English and Spanish for this purpose. It takes only about 5 minutes to 
complete, has been tested internationally in primary care settings, and has high 
levels of validity and reliability.13 You may photocopy these pages or download 
them from www.niaaa.nih.gov/guide. 
Scoring the AUDIT 
Record the score for each response in the blank box at the end of each line, 
then total these numbers. The maximum possible total is 40. 
Total scores of 8 or more for men up to age 60 or 4 or more for women, 
adolescents, and men over 60 are considered positive screens.14,15,16 For patients 
with totals near the cut-points, clinicians may wish to examine individual 
responses to questions and clarify them during the clinical examination. 
Note: The AUDIT’s sensitivity and specificity for detecting heavy drinking 
and alcohol use disorders varies across different populations. Lowering the 
cut-points increases sensitivity (the proportion of “true positive” cases) while 
increasing the number of false positives. Thus, it may be easier to use a 
cut-point of 4 for all patients, recognizing that more false positives may be 
identified among men. 
Continuing with screening and assessment 
After the AUDIT is completed, continue with Step 1, page 4. 
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CLINICIAN SUPPORT MATERIALS 
PATIENT: Because alcohol use can affect your health and can interfere with certain medications and treatments, it 
is important that we ask some questions about your use of alcohol. Your answers will remain confidential, so please 
be honest. 
Place an X in one box that best describes your answer to each question. 
Questions 0 1 2 3 4 
1. How often do you have a drink Never Monthly 2 to 4 2 to 3 4 or more 
containing alcohol? or less times a month times a week times a week 
2. How many drinks containing 1 or 2 3 or 4 5 or 6 7 to 9 10 or more 
alcohol do you have on a typical 
day when you are drinking? 
3. How often do you have 5 or more Never Less than Monthly Weekly Daily or 
drinks on one occasion? monthly almost daily 
4. How often during the last year Never Less than Monthly Weekly Daily or 
have you found that you were not monthly almost daily 
able to stop drinking once you 
had started? 
5. How often during the last year Never Less than Monthly Weekly Daily or 
have you failed to do what was monthly almost daily 
normally expected of you because 
of drinking? 
6. How often during the last year Never Less than Monthly Weekly Daily or 
have you needed a first drink in monthly almost daily 
the morning to get yourself going 
after a heavy drinking session? 
7. How often during the last year Never Less than Monthly Weekly Daily or 
have you had a feeling of guilt or monthly almost daily 
remorse after drinking? 
8. How often during the last year Never Less than Monthly Weekly Daily or 
have you been unable to remem­ monthly almost daily 
ber what happened the night 
before because of your drinking? 
9. Have you or someone else been No Yes, but not in Yes, during 
injured because of your drinking? the last year the last year 
10. Has a relative, friend, doctor, or No Yes, but not in Yes, during 
other health care worker been the last year the last year 
concerned about your drinking or 
suggested you cut down? 
Total 
Note: This questionnaire (the AUDIT) is reprinted with permission from the World Health Organization. To reflect standard drink sizes in the 
United States, the number of drinks in question 3 was changed from 6 to 5. A free AUDIT manual with guidelines for use in primary care 
settings is available online at www.who.org. 
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PACIENTE: Debido a que el uso del alcohol puede afectar su salud e interferir con ciertos medicamentos y 
tratamientos, es importante que le hagamos algunas preguntas sobre su uso del alcohol. Sus respuestas serán 
confidenciales, así que sea honesto por favor. 
Marque una X en el cuadro que mejor describa su respuesta a cada pregunta. 
Preguntas 0 1 2 3 4 
1. ¿Con qué frecuencia consume Nunca Una o De 2 a 4 De 2 a 3 4 o más 
alguna bebida alcohólica? menos veces al mes más veces veces a 
veces al mes a la semana la semana 
2. ¿Cuantas consumiciones de bebidas 1 o 2 3 o 4 5 o 6 De 7 a 9 10 o más 
alcohólicas suele realizar en un día 
de consumo normal? 
3. ¿Con qué frecuencia toma 5 o más Nunca Menos de Mensualmente Semanalmente A diario o 
bebidas alcohólicas en un solo día? una vez casi a diario 
al mes 
4. ¿Con qué frecuencia en el curso del 
último año ha sido incapaz de parar 
de beber una vez había empezado? 
Nunca Menos de 
una vez 
al mes 
Mensualmente Semanalmente A diario o 
casi a diario 
5. ¿Con qué frecuencia en el curso del Nunca Menos de Mensualmente Semanalmente A diario o 
último año no pudo hacer lo que se una vez casi a diario 
esperaba de usted porque había al mes 
bebido? 
6. ¿Con qué frecuencia en el curso del Nunca Menos de Mensualmente Semanalmente A diario o 
último año ha necesitado beber en una vez casi a diario 
ayunas para recuperarse después de al mes 
haber bebido mucho el día anterior? 
7. ¿Con qué frecuencia en el curso del Nunca Menos de Mensualmente Semanalmente A diario o 
último año ha tenido remor­ una vez casi a diario 
dimientos o sentimientos de culpa al mes 
después de haber bebido? 
8. ¿Con qué frecuencia en el curso del Nunca Menos de Mensualmente Semanalmente A diario o 
último año no ha podido recordar una vez casi a diario 
lo que sucedió la noche anterior al mes 
porque había estado bebiendo? 
9. ¿Usted o alguna otra persona ha No Sí, pero no Sí, el último 
resultado herido porque usted había en el curso del año 
bebido? último año 
10. ¿Algún familiar, amigo, médico o No Sí, pero no Sí, el último 
profesional sanitario ha mostrado en el curso del año 
preocupación por un consumo de último año 
bebidas alcohólicas o le ha sugerido 
que deje de beber? 
Total 
Note: This questionnaire (the AUDIT) is reprinted with permission from the World Health Organization and the Generalitat Valenciana 
Conselleria De Benestar Social. To reflect standard drink sizes in the United States, the number of drinks in question 3 was changed from 6 to 5. 
A free AUDIT manual with guidelines for use in primary care is available online at www.who.org. 
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Prescribing Medications for Alcohol Dependence 
Three oral medications (naltrexone, acamprosate, and disulfiram) and one 
injectable medication (extended-release injectable naltrexone) are currently 
approved for treating alcohol dependence. They have been shown to help 
patients reduce drinking, avoid relapse to heavy drinking, achieve and maintain 
abstinence, or gain a combination of these effects. As is true in treating any 
chronic illness, addressing patient adherence systematically will maximize the 
effectiveness of these medications (see “Supporting Patients Who Take 
Medications for Alcohol Dependence,” page 17). 
When should medications be considered for treating an alcohol use 
disorder? 
All approved drugs have been shown to be effective adjuncts to the treatment of 
alcohol dependence. Thus, consider adding medication whenever you’re treat­
ing someone with active alcohol dependence or someone who has stopped 
drinking in the past few months but is experiencing problems such as craving 
or slips. Patients who have previously failed to respond to psychosocial 
approaches alone are particularly strong candidates. 
Must patients agree to abstain? 
No matter which alcohol dependence medication is used, patients who have a 
goal of abstinence, or who can abstain even for a few days prior to starting the 
medication, are likely to have better outcomes. Still, it’s best to determine indi­
vidual goals with each patient. Some patients may not be willing to endorse 
abstinence as a goal, especially at first. If a patient with alcohol dependence 
agrees to reduce drinking substantially, it’s best to engage him or her in that 
goal while continuing to note that abstinence remains the optimal outcome. 
A patient’s willingness to abstain has important implications for the choice of 
medication. Most studies on effectiveness have required patients to abstain 
before starting treatment. A study of oral naltrexone, however, demonstrated a 
modest reduction in the risk of heavy drinking in people with mild dependence 
who chose to cut down rather than abstain.17 A study of injectable naltrexone 
suggests that it, too, may reduce heavy drinking in dependent patients who are 
not yet abstinent, although it had a more robust effect in those who abstained 
for 7 days before starting treatment18 and is only approved for use in those who 
can abstain in an outpatient setting before treatment begins. Acamprosate, too, 
is only approved for use in patients who are abstinent at the start of treatment. 
And disulfiram is contraindicated in patients who wish to continue to drink, 
because a disulfiram-alcohol reaction occurs with any alcohol intake at all. 
Which of the medications should be prescribed? 
Which medication to use will depend on clinical judgment and patient prefer­
ence. Each has a different mechanism of action. Some patients may respond 
better to one type of medication than another.   
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Naltrexone 
Mechanism: Naltrexone blocks opioid receptors that are involved in the rewarding 
effects of drinking alcohol and the craving for alcohol. It’s available in two forms: oral 
(Depade®, ReVia®), with once daily dosing, and extended-release injectable 
(Vivitrol®), given as once monthly injections. 
Efficacy: Oral naltrexone reduces relapse to heavy drinking, defined as 4 or more drinks 
per day for women and 5 or more for men.19,20 It cuts the relapse risk during the first 
3 months by about 36 percent (about 28 percent of patients taking naltrexone relapse 
versus about 43 percent of those taking a placebo).20 Thus, it is especially helpful for 
curbing consumption in patients who have drinking “slips.” It is less effective in 
maintenance of abstinence.19,20 In the single study available when this Guide update was 
published, extended-release injectable naltrexone resulted in a 25 percent reduction in 
the proportion of heavy drinking days compared with a placebo, with a higher rate of 
response in males and those with lead-in abstinence.18 
Acamprosate 
Mechanism: Acamprosate (Campral®) acts on the GABA and glutamate 
neurotransmitter systems and is thought to reduce symptoms of protracted abstinence 
such as insomnia, anxiety, restlessness, and dysphoria. It’s available in oral form (three 
times daily dosing). 
Efficacy: Acamprosate increases the proportion of dependent drinkers who maintain 
abstinence for several weeks to months, a result demonstrated in multiple European 
studies and confirmed by a meta-analysis of 17 clinical trials.21 The meta-analysis 
reported that 36 percent of patients taking acamprosate were continuously abstinent 
at 6 months, compared with 23 percent of those taking a placebo. 
More recently, two large U.S. trials failed to confirm the efficacy of acamprosate,22,23 
although secondary analyses in one of the studies suggested possible efficacy in patients 
who had a baseline goal of abstinence.23 A reason for the discrepancy between European 
and U.S. findings may be that patients in European trials had more severe dependence 
than patients in U.S. trials,21,22 a factor consistent with preclinical studies showing that 
acamprosate has a greater effect in animals with a prolonged history of dependence.24 
In addition, before starting medication, most patients in European trials had been 
abstinent longer than patients in U.S. trials.25 
Disulfiram 
Mechanism: Disulfiram (Antabuse®) interferes with degradation of alcohol, resulting 
in accumulation of acetaldehyde which, in turn, produces a very unpleasant reaction 
including flushing, nausea, and palpitations if the patient drinks alcohol. It’s available 
in oral form (once daily dosing). 
Efficacy: The utility and effectiveness of disulfiram are considered limited because 
compliance is generally poor when patients are given it to take at their own discretion.26 
It is most effective when given in a monitored fashion, such as in a clinic or by a 
spouse.27 (If a spouse or other family member is the monitor, instruct both monitor and 
patient that the monitor should simply observe the patient taking the medication and 
call you if the patient stops taking the medication for 2 days.) Some patients will 
respond to self-administered disulfiram, however, especially if they’re highly motivated 
to abstain. Others may use it episodically for high-risk situations, such as social 
occasions where alcohol is present. 
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How long should medications be maintained? 
The risk for relapse to alcohol dependence is very high in the first 6 to 
12 months after initiating abstinence and gradually diminishes over several 
years. Therefore, a minimum initial period of 3 months of pharmacotherapy is 
recommended. Although an optimal treatment duration hasn’t been established, 
it isn’t unreasonable to continue treatment for a year or longer if the patient 
responds to medication during this time when the risk of relapse is highest. 
After patients discontinue medications, they may need to be followed more 
closely and have pharmacotherapy reinstated if relapse occurs. 
If one medication doesn’t work, should another be prescribed? 
If there’s no response to the first medication selected, you may wish to consider 
a second. This sequential approach appears to be common clinical practice, 
but currently there are no published studies examining its effectiveness. 
Similarly, there is not yet enough evidence to recommend a specific ordering 
of medications. 
Is there any benefit to combining medications? 
A large U.S. trial found no benefit to combining acamprosate and naltrexone.22 
More broadly, there is no evidence that combining any of the medications to 
treat alcohol dependence improves outcomes over using any one medication 
alone. 
Should patients receiving medications also receive specialized alcohol 
counseling or a referral to mutual help groups? 
Offering the full range of effective treatments will maximize patient choice and 
outcomes, since no single approach is universally successful or appealing to 
patients. The different approaches—medications for alcohol dependence, 
professional counseling, and mutual help groups—are complementary. They 
share the same goals while addressing different aspects of alcohol dependence: 
neurobiological, psychological, and social. The medications aren’t prone to 
abuse, so they don’t pose a conflict with other support strategies that emphasize 
abstinence. 
Almost all studies of medications for alcohol dependence have included some 
type of counseling, and it’s recommended that all patients taking these medica­
tions receive at least brief medical counseling. In a recent large trial, the combi­
nation of oral naltrexone and brief medical counseling sessions delivered by a 
nurse or physician was effective without additional behavioral treatment by a 
specialist.22 Patients were also encouraged to attend support groups to increase 
social encouragement for abstinence. For more information, see “Supporting 
Patients Who Take Medications for Alcohol Dependence” on page 17 and 
“Should I recommend any particular behavioral therapy for patients with 
alcohol use disorders?” on page 31. 
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The information in this chart was drawn primarily from package inserts and references 18, 20, 22, and 26 (see pages 33–34). 
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Supporting Patients Who Take Medications for 
Alcohol Dependence 
Pharmacotherapy for alcohol dependence is most effective when combined 
with some behavioral support, but this doesn’t need to be specialized, intensive 
alcohol counseling. Nurses and physicians in general medical and mental health 
settings, as well as counselors, can offer brief but effective behavioral support 
that promotes recovery. Applying this medication management approach in 
such settings would greatly expand access to effective treatment, given that 
many patients with alcohol dependence either don’t have access to specialty 
treatment or refuse a referral.  
How can general medical and mental health clinicians support patients 
who take medication for alcohol dependence? 
Managing the care of patients who take medication for alcohol dependence is 
similar to other disease management strategies such as initiating insulin therapy 
in patients with diabetes mellitus. In the recent Combining Medications and 
Behavioral Interventions (COMBINE) clinical trial, physicians, nurses, and 
other health care professionals in outpatient settings delivered a series of brief 
behavioral support sessions for patients taking medications for alcohol depend­
ence.22 The sessions promoted recovery by increasing adherence to medication 
and supporting abstinence through education and referral to support groups.22 
This Guide offers a set of how-to templates outlining this program (see pages 
19–22). It was designed for easy implementation in nonspecialty settings, in 
keeping with the national trend toward integrating the treatment of substance 
use disorders into medical practice. 
What are the components of medication management support? 
Medication management support consists of brief, structured outpatient 
sessions conducted by a health care professional. The initial session starts by 
reviewing the medical evaluation results with the patient as well as the negative 
consequences from drinking. This information frames a discussion about the 
diagnosis of alcohol dependence, the recommendation for abstinence, and the 
rationale for medication. The clinician then provides information on the 
medication itself and adherence strategies, and encourages participation in a 
mutual support group such as Alcoholics Anonymous (AA). 
In subsequent visits, the clinician assesses the patient’s drinking, overall 
functioning, medication adherence, and any side effects from the medication. 
Session structure varies according to the patient’s drinking status and treatment 
compliance, as outlined on page 22. When a patient doesn’t adhere to the 
medication regimen, it’s important to evaluate the reasons and help the patient 
devise plans to address them. A helpful summary of strategies for handling 
nonadherence is provided in the “Medical Management Treatment Manual” 
from Project COMBINE, available online at www.niaaa.nih.gov/guide. 
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As conducted in the COMBINE trial, the program consisted of an initial 
session of about 45 minutes followed by eight 20-minute sessions during 
weeks 1, 2, 4, 6, 8, 10, 12, and 16. General medical or mental health practices 
may not follow this particular schedule, but it’s offered along with the 
templates as a starting point for developing a program that works for your 
practice and your patients. 
Can medication management support be used with patients who don’t 
endorse a goal of abstinence? 
This medication management program has been tested only in patients for 
whom abstinence was recommended, as is true with most pharmacotherapy 
studies. It’s not known whether it would also work if the patient’s goal is to cut 
back instead of abstain. Even when patients do endorse abstinence as a 
goal, they often cut back without quitting. You’re encouraged to continue 
working with those patients who are working toward recovery but haven’t yet 
met the optimal goals of abstinence or reduced drinking with full remission 
of dependence symptoms. You may also find many of the techniques used in 
medication management support—such as linking symptoms and laboratory 
results with heavy alcohol use—to be helpful for managing alcohol-dependent 
patients in general. 
18 
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Initial Session Template 
page 1 of 2 
Medication Management Support for Alcohol Dependence 
This template outlines the first in a series of appointments designed to support patients diagnosed with alcohol

dependence who are starting a course of medication to help them maintain abstinence. 

Date: Time spent: 

Patient name: 

Pertinent history: 

Observations: 

Before counseling:  
Record from the patient’s chart:  
Alcohol-dependence medication prescribed: 
naltrexone PO  XR-naltrexone injectable acamprosate  disulfiram other: 
dose and schedule: 
Lab results and other patient information (fill in the left column of the chart below, to the degree possible) 
Gather: 
Patient information on the medication (available, for example, from www.medlineplus.gov) 
Wallet emergency card for naltrexone or disulfiram (see www.niaaa.nih.gov/guide) 
Listing of local mutual help groups. For AA, see www.aa.org; for other groups, see the National 
Clearinghouse for Alcohol and Drug Information Web site at www.ncadi.samhsa.gov under “Resources.” 
Patient information— 
from the chart or patient report, 
this forms the basis for counseling 
Counseling— 
delivered in a nonjudgmental way, this enhances patient 
motivation and provides the rationale for medication 
1 Review lab results and medical adverse 
consequences of heavy drinking: 
Liver function test results: 
AST (SGOT): 
ALT (SGPT): 
GGT (GGTP): 
Total Bilirubin: 
Albumin: 
Blood pressure: / Pulse: 
Other medical conditions affected by drinking 
and relevant lab results: 
diabetes heart disease  GI: 
insomnia depression  anxiety pain 
other: 
other relevant lab results (e.g., MCV): 
Tie results and symptoms to heavy alcohol use: 
Describe normal liver function and adverse effects of 
heavy drinking, then discuss results of liver function 
tests: 
If normal range: “This is a positive sign that your liver has avoided 
harm so far, and that now you have the opportunity to keep it 
that way by changing your drinking habits. Having a healthy liver 
will also help you make a quicker, more complete recovery.” 
If abnormal: “The test results are most likely a sign of unhealthy 
changes in your liver from heavy alcohol use. The longer you 
continue to drink, the harder it is to reverse the damage. But if 
you stop drinking, you may be able to get your liver function 
back to normal.” 
If blood pressure is elevated, describe relationship 
between high blood pressure and heavy drinking. 
Describe relationship between condition(s) and heavy 
drinking, including relevant lab results. 
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Initial—page 2 of 2 
Review amount of drinking and nonmedical 
adverse consequences of heavy drinking: 
Amount of drinking: When was last drink? 
In the past 30 days, 
— how many drinking days (any alcohol): days 
— how many heavy drinking days (5+ drinks/day for men, 
4+ drinks/day for women): days 
Nonmedical adverse consequences: 
interpersonal employment/school  legal 
specify: 
2 Focus more on the consequences of drinking than 
on the quantity: 
“I see that when you drink, you drink heavily, and that you’ve 
reported some problems related to that, such as (x). We see these 
as (additional) signs that drinking is harmful for you.” 
Confirm diagnosis of alcohol dependence. 3 Recommend abstinence and provide rationale for 
medications: 
“You have a diagnosis of alcohol dependence.” (Provide patient 
materials if available.) “We strongly recommend that you stop 
drinking altogether. For someone with alcohol dependence, this 
is the safest choice. It’s also best for your health. Quitting is 
hard, which is why a medication has been prescribed that may 
help you abstain.” 
Review the patient’s decision on abstinence: 
Is the patient willing to abstain? yes  no 
Comment: 
4 If the patient is unwilling or unable to commit to 
abstinence, offer a trial period: 
“If you’re thinking that lifelong abstinence is too difficult a goal to 
commit to right now, you could try a brief period of, say, a month 
to find out what it’s like to live without alcohol. Would you be 
willing to try this out?” 
If a trial of abstinence isn’t accepted, reconsider whether 
medication is still appropriate with a modified goal. 
Provide medication counseling, focusing on 5 
6 
7 
Mechanism of action and time course of effects. Describe how Adherence strategies. Discuss the patient’s history of pill-taking 
the medication works and how long it may take to be effective. practices, then strategies to promote adherence, such as taking pills 
Potential side effects. Discuss the likelihood of side effects at the same time each day, using weekly pill containers, and 
(see the package insert) and ways to cope with adverse events enlisting others’ support. 
such as nausea or diarrhea. Advise the patient to contact you if Emergency cards. For naltrexone, educate the patient about 
concerned about side effects. potential complications with opioid use and analgesics. For disulfi-
Dosing and adherence. Review the dosing regimen, remind the ram, educate the patient about the alcohol-disulfiram reaction and 
patient to take the medication consistently for effectiveness, and avoiding alcohol in food and medicines. Give the patient wallet 
explain what to do if a dose is skipped. emergency cards: (initials and date) 
Encourage participation in a mutual support group: 
Provide list of local options and describe the benefits of • If the patient has attended a meeting before and wasn’t 
attendance. Note that attending AA or another mutual support comfortable: “Not all groups are alike. It’s likely that you’ll 
group is a way to acquire a network of friends who have found need to try several before finding one that feels right.” 
ways to live without alcohol. Tell the patient that medication is • If the patient is concerned about members disapproving of his 
time limited and that the importance of mutual support groups or her medication: “The medication is a tool you’ll use in an 
increases when medications are stopped. effort not to drink. It has been shown to help others stop 
Address barriers to attendance: drinking. Also, it’s not addicting. And the official policy of AA 
•	 If the patient is reluctant to attend: “Would you be willing to supports people taking nonaddicting medicines prescribed by 
try just one meeting before our next session?” a doctor.” 
Wrap up: Summarize the diagnosis and Ask about remaining questions Other followup: 
recommendation for abstinence or concerns 
Summarize dosage regimen Schedule the next visit 
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Followup Session Template	
page 1 of 2 
Medication Management Support for Alcohol Dependence 
Date: Time spent: 

Patient name: 

Vital signs (if taken):  BP: / P: Weight: 

Laboratory data (if available):  GGT: AST: ALT: Other: 

General progress and patient concerns since the last visit: 

Observations of patient cognition: Mood: 
Physical signs: Other: 
Drinking status 
•	 How long since the last drink? days/weeks/months 
•	 In the past 30 days (or since the last visit if less than 30 days): 
—	 how many drinking days (any alcohol): days in the past days 
—	 how many heavy drinking days (5+ drinks/day for men, 4+ drinks/day for women): 

days in the past days 

•	 Other: 
Alcohol pharmacotherapy  
•	 Medications prescribed: none naltrexone PO  XR-naltrexone injectable acamprosate  
disulfiram other: 
•	 In the past 30 days (or since the last visit if less than 30 days), how many days has the patient taken 
medication? days in the past days 
•	 Side effects: none nausea vomiting  diarrhea headache injection site reaction 
other: 
•	 Patient’s perception of the medication’s effectiveness: helpful not helpful not sure  
specify: 
Other treatment received 
Since your last visit, have you: 
Yes     No 
Started any new medications? (specify) 

Attended mutual support groups? If yes, how often? 

Received alcohol or addiction counseling? (specify) 

Received other counseling? (specify) 

Entered a treatment program? 

residential  intensive outpatient  other (specify) 

Been hospitalized for alcohol or drug use? (specify) 

Been treated for withdrawal (shakes)? (specify) 
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Counseling provided (check the dialogue used) 
Is the patient drinking? 
NO 
Is the patient adherent 
to medications? 
NO 
Congratulate the 
patient for not 
drinking 
Review the benefits 
of pharmacotherapy 
Ask why the 
medications are not 
taken regularly 
Explore possible 
remedies to correct 
nonadherence 
Set the next 
appointment 
YES 
Reinforce the 
patient’s ability to 
follow advice and 
stick to the plan 
Ask what the patient 
has done to achieve 
this outcome 
Encourage the 
patient to stick with 
the plan—“Keep up 
the good work!” 
Review the benefits 
of abstinence 
Set the next

appointment

YES 
Is the patient adherent 
to medications? 
NO 
Review the initial 
reasons for seeking 
treatment (i.e., 
negative consequences 
of drinking) 
Review the benefits 
of abstinence and 
pharmacotherapy 
Review the reasons 
for medication 
nonadherence 
Create a new adherence 
plan, addressing 
barriers to treatment 
and providing sugges­
tions on minimizing 
drinking cues 
Encourage the patient 
to “give treatment a 
chance” 
Set the next

appointment

YES 
Praise any small steps 
toward abstinence 
(e.g., fewer heavy 
drinking days) 
Review the benefits 
of abstinence 
Review the benefits 
of mutual support 
group meetings 
Remind the patient 
that medications take 
time to work 
Set the next

appointment 

Followup—page 2 of 2 
Other recommendations (e.g., side effects management, new adherence plan): 
Followup:
 Continue the current treatment plan  

Change the treatment plan as follows: 

(for nurses): Refer to physician for medical evaluation 
Next appointment date: 
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Referral Resources 
When making referrals, involve your patient in the decisions and schedule a 
referral appointment while he or she is in your office. 
Finding evaluation and treatment options 
For patients with insurance, contact a behavioral health case manager at the 
insurance company for a referral. 
For patients who are uninsured or underinsured, contact your local health 
department about addiction services. 
For patients who are employed, ask whether they have access to an 
Employee Assistance Program with addiction counseling. 
To locate treatment options in your area: 
•	 Call local hospitals to see which ones offer addiction services. 
•	 Call the National Drug and Alcohol Treatment Referral Routing Service 
(1-800-662-HELP) or visit the Substance Abuse Facility Treatment 
Locator Web site at http://findtreatment.samhsa.gov. 
Finding support groups 
Alcoholics Anonymous (AA) offers free, widely available groups of 
volunteers in recovery from alcohol dependence. Volunteers are often 
willing to work with professionals who refer patients. For contact 
information for your region, visit www.aa.org. 
Other mutual help organizations that offer secular approaches, groups for 
women only, or support for family members can be found on the National 
Clearinghouse for Alcohol and Drug Information Web site 
(www.ncadi.samhsa.gov) under “Resources.” 
Local resources 
Use the space below for contact information for resources in your area 
(treatment centers, mutual support groups such as AA, local government servic­
es, the closest Veterans Affairs medical center, shelters, churches). 
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What’s a Standard Drink?

A standard drink in the United States is any drink that contains about 14 grams of pure alcohol (about 
0.6 fluid ounces or 1.2 tablespoons). Below are U.S. standard drink equivalents. These are approximate, 
since different brands and types of beverages vary in their actual alcohol content. 
12 oz. of 
beer or 
cooler 
5 oz. of 
table wine 
3–4 oz. of 
fortified wine 
(such as 
sherry or port) 
3.5 oz. shown 
2–3 oz. of 
cordial, 
liqueur, or 
aperitif 
2.5 oz. shown 
1.5 oz. of 
brandy 
(a single jigger) 
1.5 oz. of 
spirits 
(a single jigger 
of 80-proof 
gin, vodka, 
whiskey, etc.) 
Shown straight and 
in a highball glass 
with ice to show 
the level before 
adding a mixer* 
8–9 oz. of 
malt liquor 
8.5 oz. shown in 
a 12-oz. glass that, 
if full, would hold 
about 1.5 standard 
drinks of malt liquor 
~5% alcohol ~7% alcohol ~12% alcohol ~17% alcohol ~24% alcohol ~40% alcohol ~40% alcohol 
▼ ▼ ▼ ▼ ▼ ▼ ▼ 
12 oz. 8.5 oz. 5 oz. 3.5 oz. 2.5 oz. 1.5 oz. 1.5 oz. 
Many people don’t know what counts as a standard drink and so they don’t realize how many standard 
drinks are in the containers in which these drinks are often sold. Some examples: 
For beer, the approximate number of standard drinks in 
• 12 oz. = 1 • 22 oz. = 2 
• 16 oz. = 1.3 • 40 oz. = 3.3 
For malt liquor, the approximate number of standard drinks in 
• 12 oz. = 1.5 • 22 oz. = 2.5 
• 16 oz. = 2 • 40 oz. = 4.5 
For table wine, the approximate number of standard drinks in 
• a standard 750-mL (25-oz.) bottle = 5 
For 80-proof spirits, or “hard liquor,” the approximate number of standard drinks in 
• a mixed drink = 1 or more* • a fifth (25 oz.) = 17 
• a pint (16 oz.) = 11 • 1.75 L (59 oz.) = 39 
*Note: It can be difficult to estimate the number of standard drinks in a single mixed drink made with hard 
liquor. Depending on factors such as the type of spirits and the recipe, a mixed drink can contain from one to 
three or more standard drinks. 
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U.S. Adult Drinking Patterns 
Nearly 3 in 10 U.S. adults engage in at-risk drinking patterns3 and thus would benefit from advice to cut down 
or a referral for further evaluation. During a brief intervention, you can use this chart to show that (1) most people 
abstain or drink within the recommended limits and (2) the prevalence of alcohol use disorders rises with heavier 
drinking. Though a wise first step, cutting to within the limits is not risk free, since motor vehicle crashes and other 
problems can occur at lower drinking levels. 
WHAT’S 
YOUR 
DRINKING 
PATTERN? 
HOW 
COMMON 
IS THIS 
PATTERN? 
HOW COMMON ARE 
ALCOHOL DISORDERS 
IN DRINKERS WITH 
THIS PATTERN? 
Based on the following limits—number of drinks: 
On any DAY—Never more than 4 (men) or 3 (women) 
– and – 
In a typical WEEK—No more than 14 (men) or 7 (women) 
Percentage of 
U.S. adults 
aged 18 
or older* 
Combined 
prevalence 
of alcohol abuse 
and dependence** 
Never exceed the daily or weekly limits 
(2 out of 3 people in this group abstain or 
drink fewer than 12 drinks a year) 
72% 
fewer than 
1 in 100 
Exceed only the daily limit 
(More than 8 out of 10 in this group exceed 
the daily limit less than once a week) 
16% 
1 in 5 
Exceed both daily and weekly limits 
(8 out of 10 in this group exceed 
the daily limit once a week or more) 
10% 
almost 
1 in 2 
* Not included in the chart, for simplicity, are the 2 percent of U.S. adults who exceed only the weekly limits. The combined prevalence of alcohol use 
disorders in this group is 8 percent. 
** See page 5 for the diagnostic criteria for alcohol disorders. 
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Strategies for Cutting Down 
Small changes can make a big difference in reducing your chances of having alcohol-related problems. Here are some 
strategies to try. Check off some to try the first week, and add some others the next. 
Keeping track 
Keep track of how much you drink. Find a way that works for you, such as a 3x5" card in your wallet, check marks on 
a kitchen calendar, or a personal digital assistant. If you make note of each drink before you drink it, this will help you 
slow down when needed. 
Counting and measuring 
Know the standard drink sizes so you can count your drinks accurately. One standard drink is 12 ounces of regular 
beer, 8 to 9 ounces of malt liquor, 5 ounces of table wine, or 1.5 ounces of 80-proof spirits. Measure drinks at home. 
Away from home, it can be hard to know the number of standard drinks in mixed drinks. To keep track, you may 
need to ask the server or bartender about the recipe. 
Setting goals 
Decide how many days a week you want to drink and how many drinks 

you’ll have on those days. You can reduce your risk of alcohol dependence

and related problems by drinking within the limits in the box to the right. 

It’s a good idea to have some days when you don’t drink.

Pacing and spacing 
When you do drink, pace yourself. Sip slowly. Have no more than one 

drink with alcohol per hour. Alternate “drink spacers”—nonalcoholic 

drinks such as water, soda, or juice—with drinks containing alcohol.

Including food 
Don’t drink on an empty stomach. Have some food so the alcohol will 
be absorbed more slowly into your system. 
Avoiding “triggers” 
What triggers your urge to drink? If certain people or places make you 

drink even when you don’t want to, try to avoid them. If certain activities,

times of day, or feelings trigger the urge, plan what you’ll do instead of

drinking. If drinking at home is a problem, keep little or no alcohol there. 

MAXIMUM DRINKING LIMITS 
FOR HEALTHY ADULTS* 
For healthy men up to age 65— 
• no more than 4 drinks in a day 
AND 
• no more than 14 drinks in a week 
For healthy women (and healthy 
men over age 65)— 
• no more than 3 drinks in a day 
AND 
• no more than 7 drinks in a week 
* Depending on your health status, your doctor 
may advise you to drink less or abstain. 
Planning to handle urges 
When an urge hits, consider these options: Remind yourself of your reasons for changing. Or talk it through with 
someone you trust. Or get involved with a healthy, distracting activity. Or “urge surf”—instead of fighting the feeling, 
accept it and ride it out, knowing that it will soon crest like a wave and pass. 
Knowing your “no” 
You’re likely to be offered a drink at times when you don’t want one. Have a polite, convincing “no, thanks” ready. 
The faster you can say no to these offers, the less likely you are to give in. If you hesitate, it allows you time to think 
of excuses to go along. 
Additional tips for quitting 
If you want to quit drinking altogether, the last three strategies can help. In addition, you may wish to ask for support 
from people who might be willing to help, such as a significant other or nondrinking friends. Joining Alcoholics 
Anonymous or another mutual support group is a way to acquire a network of friends who have found ways to live with­
out alcohol. If you’re dependent on alcohol and decide to stop drinking completely, don’t go it alone. Sudden withdrawal 
from heavy drinking can cause dangerous side effects such as seizures. See a doctor to plan a safe recovery. 
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Online Materials for Clinicians and Patients 
Visit the NIAAA Web site at www.niaaa.nih.gov/guide for these and other materials to support you in alcohol 
screening, brief interventions, and followup patient care. NIAAA continually develops and updates materials 
for practitioners and patients; please check the Web site for new offerings. You may also order materials by 
writing to the NIAAA Publications Distribution Center, P.O. Box 10686, Rockville, MD 20849-0686 or 
calling 301–443–3860. 
Clinician support and training 
Forms for downloading 
•	 Screening instrument: The Alcohol Use Disorders Identification Test 
(AUDIT) in English and Spanish 
•	 Assessment support: Sample questions for assessment of alcohol use disorders 
•	 Preformatted progress notes and templates 
o	 Baseline and followup progress notes 
o	 Medication management support templates 
•	 Medication wallet card form 
Animated slide show 
•	 This 80-slide PowerPoint™ show helps instructors present the content of the 
Guide to students and professionals in the general medicine and mental health 
fields. 
Online training 
•	 Coming in spring 2007: Online training in screening and brief intervention 
for Continuing Medical Education credit. 
Publications for professionals 
•	 Alcohol Alerts: These 4-page bulletins provide timely information on alcohol 
research and treatment. 
•	 Alcohol Research & Health: Each issue of this quarterly peer-reviewed journal 
contains review articles on a central topic related to alcohol research. 
•	 A Pocket Guide for Alcohol Screening and Brief Intervention: This is a 
condensed, portable version of this publication. 
•	 Spanish edition of the Guide: Ayudando a Pacientes Que Beben en Exceso— 
Guia Para Profesionales de la Salud. 
Patient education 
Handouts for downloading 
•	 In English and Spanish: Strategies for Cutting Down; U.S. Adult Drinking 
Patterns; What’s a Standard Drink? 
Publications for the public 
•	 In English and Spanish: Alcohol: A Women’s Health Issue; Frequently Asked 
Questions about Alcoholism and Alcohol Abuse; A Family History of Alcoholism: 
Are You at Risk? and more 
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Frequently Asked Questions 
About alcohol screening and brief 
interventions 
How effective is screening for heavy drinking? 
Studies have demonstrated that screening is 
sensitive and that patients are willing to give honest 
information about their drinking to health care 
practitioners when appropriate methods are used.6,15 
Several methods have been shown to work, 
including quantity-frequency interview questions 
and questionnaires such as the CAGE, the AUDIT, 
the shorter AUDIT-C, the TWEAK (for pregnant 
women), and others.28,29 In this Guide, the single 
screening question about heavy drinking days was 
chosen for its simplicity and because almost all 
people with alcohol use disorders report drinking 
5 or more drinks in a day (for men) or 4 or more 
(for women) at least occasionally. This Guide also 
recommends the AUDIT (provided on page 11) 
as a self-administered screening tool because of 
its high levels of validity and reliability.15 
With the single interview question, screening is 
positive with just one heavy drinking day in the 
past year. Isn’t that casting a very broad net? 
A common reaction to the screening question 
is, “Everybody’s going to meet this, at least 
occasionally.” A large national survey by NIAAA, 
however, showed that nearly three-fourths of U.S. 
adults never exceed the limits in the screening 
question.3 Even if patients report that they only 
drink heavily on rare occasions, screening provides 
an opportunity to educate them about safe 
drinking limits so that heavy drinking doesn’t 
become more frequent. The risk for alcohol-related 
problems rises with the number of heavy drinking 
days,1 and some problems, such as driving while 
intoxicated or trauma, can occur with a single 
occasion. 
How effective are brief interventions? 
Randomized, controlled clinical trials in a variety 
of populations and settings have shown that brief 
interventions can decrease alcohol use significantly 
among people who drink above the recommended 
limits but aren’t dependent. In several intervention 
trials with multiple brief contacts, for example, 
heavy drinkers cut an average of three to nine 
drinks per week, for a 13 to 34 percent net 
reduction in consumption.30 Even relatively modest 
reductions in drinking can have important health 
benefits when spread across a large number of 
people. Brief intervention trials have also reported 
significant decreases in blood pressure readings, 
levels of gamma-glutamyl transferase (GGT), 
psychosocial problems, hospital days, and hospital 
readmissions for alcohol-related trauma.8 Followup 
periods typically range from 6 to 24 months, 
although one recent study reported sustained 
reductions in alcohol use over 48 months.8 A cost-
benefit analysis in this study showed that each 
dollar invested in brief physician intervention could 
reap more than fourfold savings in future health 
care costs. Other research shows that for alcohol-
dependent patients with an alcohol-related medical 
illness, repeated brief interventions at approximate­
ly monthly intervals for 1 to 2 years can lead to 
significant reductions in or cessation of drinking.9,10 
What can I do to encourage my patients to give 
honest and accurate answers to the screening 
questions? 
It’s often best to ask about alcohol consumption 
at the same time as other health behaviors such 
as smoking, diet, and exercise. Using an empathic, 
nonconfrontational approach can help put patients 
at ease. Some clinicians have found that prefacing 
the alcohol questions with a nonthreatening opener 
such as “Do you enjoy a drink now and then?” can 
encourage reserved patients to talk. Patients may 
feel that a written or computerized self-report 
version of the AUDIT is less confrontational as 
well. To improve the accuracy of estimated 
drinking quantities, you could ask patients to look 
at the “What’s a Standard Drink?” chart on page 
24. Many people are surprised to learn what counts 
as a single standard drink, especially for beverages 
with a higher alcohol content such as malt liquors, 
fortified wines, and spirits. The chart also lists the 
number of standard drinks in commonly purchased 
beverage containers. In some situations, you may 
consider adding the questions “How often do you 
buy alcohol?” and “How much do you buy?” to 
help build an accurate estimate. 
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How can a clinic- or office-based screening 
system be implemented? 
The best studied method, which is both easy and 
efficient, is to ask patients to fill out the 10-item 
AUDIT before seeing the doctor. This form 
(provided on page 11) can be added to others that 
patients fill out. The full AUDIT or the 3-item 
AUDIT-C can also be incorporated into a larger 
health history form. The AUDIT-C consists of 
the first three consumption-related items of the 
AUDIT; a score of 6 or more for men and 4 or 
more for women31 indicates a positive screen. 
Alternatively, the single-item screen in Step 1 of 
this Guide could be incorporated into a health 
history form. Screening can also be done in person 
by a nurse during patient check-in. (See also 
“Set Up Your Practice to Simplify the Process” 
on page 3.) 
Are there any specific considerations for imple­
menting screening in mental health settings? 
Studies have demonstrated a strong relationship 
between alcohol use disorders and other mental 
disorders.32 Heavy drinking can cause psychiatric 
symptoms such as depression, anxiety, insomnia, 
cognitive dysfunction, and interpersonal conflict. 
For patients who have an independent psychiatric 
disorder, heavy drinking may compromise the 
treatment response. Thus, it is important that all 
mental health clinicians conduct routine screening 
for heavy drinking. 
Less is known about the performance of screening 
methods or brief interventions in mental health 
settings than in primary care settings. Still, the 
single-question screener in this Guide is likely to 
work reasonably well, since almost everyone with 
an alcohol use disorder reports drinking above the 
recommended daily limits at least occasionally. 
Mental health clinicians may need to conduct a 
more thorough assessment to determine whether an 
alcohol use disorder is present and how it might be 
interacting with other mental or substance use 
disorders. The recommended limits for drinking 
may need to be lowered depending on coexisting 
problems and prescribed medications. 
Similarly, a more extended behavioral intervention 
may be needed to address coexisting alcohol use 
disorders, either delivered as part of mental health 
treatment or through referral to an addiction 
specialist. 
About drinking levels and advice

When should I recommend abstaining versus 
cutting down? 
Certain conditions warrant advice to abstain as 
opposed to cutting down. These include when 
drinkers: 
•	 are or may become pregnant 
•	 are taking a contraindicated medication 
(see box below) 
•	 have a medical or psychiatric disorder caused by 
or exacerbated by drinking 
•	 have an alcohol use disorder 
If patients with alcohol use disorders are unwilling 
to commit to abstinence, they may be willing to 
cut down on their drinking. This should be 
encouraged while noting that abstinence, the safest 
strategy, has a greater chance of long-term success. 
For heavy drinkers who don’t have an alcohol use 
disorder, use professional judgment to determine 
whether cutting down or abstaining is more 
appropriate, based on factors such as these: 
Interactions Between Alcohol and Medications 
Alcohol can interact negatively with medications either by interfering with the metabolism of the 
medication (generally in the liver) or by enhancing the effects of the medication (particularly in the 
central nervous system). Many classes of prescription medicines can interact with alcohol, including 
antibiotics, antidepressants, antihistamines, barbiturates, benzodiazepines, histamine H2 receptor agonists, 
muscle relaxants, nonopioid pain medications and anti-inflammatory agents, opioids, and warfarin. In 
addition, many over-the-counter medications and herbal preparations can cause negative side effects when 
taken with alcohol. 
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•	 a family history of alcohol problems 
•	 advanced age 
•	 injuries related to drinking 
•	 symptoms such as sleep disorders or sexual 
dysfunction 
It may be useful to discuss different options, 
such as cutting down to recommended limits or 
abstaining completely for perhaps a month or two, 
then reconsidering future drinking. If cutting down 
is the initial strategy but the patient is unable to 
stay within limits, recommend abstinence. 
How do I factor the potential benefits of 
moderate drinking into my advice to patients 
who drink rarely or not at all? 
Moderate consumption of alcohol (defined by U.S. 
Dietary Guidelines as up to two drinks a day for 
men and one for women) has been associated with 
a reduced risk of coronary heart disease.33 Achieving 
a balance between the risks and benefits of alcohol 
consumption remains difficult, however, because 
each person has a different susceptibility to diseases 
potentially caused or prevented by alcohol. The 
advice you would give to a young person with a 
family history of alcoholism, for example, would 
differ from the advice you would give to a middle-
aged patient with a family history of premature 
heart disease. Most experts don’t recommend 
advising nondrinking patients to begin drinking 
to reduce their cardiovascular risk. However, if a 
patient is considering this, discuss safe drinking 
limits and ways to avoid alcohol-induced harm. 
Why are the recommended drinking limits lower 
for some patients? 
The limits are lower for women because they have 
proportionally less body water than men do and 
thus achieve higher blood alcohol concentrations 
after drinking the same amount of alcohol. Older 
adults also have less lean body mass and greater 
sensitivity to alcohol’s effects. In addition, there are 
many clinical situations where abstinence or lower 
limits are indicated, because of a greater risk of 
harm associated with drinking. Examples include 
women who are or may become pregnant, patients 
taking medications that may interact with alcohol, 
young people with a family history of alcohol 
dependence, and patients with physical or 
psychiatric conditions that are caused by or 
exacerbated by alcohol. 
Some of my patients who drink heavily believe 
that this is normal. What percentage of people 
drink at, above, or below moderate levels? 
About 7 in 10 adults abstain, drink rarely, or drink 
within the daily and weekly limits noted in Step 1.3 
The rest exceed the daily limits, the weekly limits, 
or both. The “U.S. Adult Drinking Patterns” chart 
on page 25 shows the percentage of drinkers in 
each category, as well as the prevalence of alcohol 
use disorders in each group. Because heavy drinkers 
often believe that most people drink as much and 
as often as they do, providing normative data about 
U.S. drinking patterns and related risks can provide 
a helpful reality check. In particular, those who 
believe that it’s fine to drink moderately during 
the week and heavily on the weekends need to 
know that they have a higher chance not only of 
immediate alcohol-related injuries, but also of 
developing alcohol use disorders and other alcohol-
related medical and psychiatric disorders. 
Some of my patients who are pregnant don’t see 
any harm in having an occasional drink. What’s 
the latest advice? 
Some pregnant women may not be aware of the 
risks involved with drinking, while others may 
drink before they realize they’re pregnant. A recent 
survey estimates that 1 in 10 pregnant women in 
the United States drinks alcohol.34 In addition, 
among sexually active women who aren’t using 
birth control, more than half drink and 12.4 
percent report binge drinking, placing them at 
particularly high risk for an alcohol-exposed 
pregnancy.34 
Each year, an estimated 2,000 to 8,000 infants are 
born with fetal alcohol syndrome in the United 
States, and many thousands more are born with 
some degree of alcohol-related effects.35 These 
problems range from mild learning and behavioral 
problems to growth deficiencies to severe mental 
and physical impairment. Together, these adverse 
effects comprise fetal alcohol spectrum disorders. 
Because it isn’t known whether any amount of 
alcohol is safe during pregnancy, the Surgeon 
General recently reissued an advisory that urges 
women who are or may become pregnant to 
abstain from drinking alcohol.2 The advisory also 
recommends that pregnant women who have 
already consumed alcohol stop to minimize further 
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risks and that health care professionals inquire 
routinely about alcohol consumption by women of 
childbearing age. 
About diagnosing and helping 
patients with alcohol use disorders 
What if a patient reports some symptoms of an 
alcohol use disorder but not enough to qualify 
for a diagnosis? 
Alcohol use disorders are similar to other medical 
disorders such as hypertension, diabetes, or 
depression in having “gray zones” of diagnosis. For 
example, a patient might report a single arrest for 
driving while intoxicated and no other symptoms. 
Since a diagnosis of alcohol abuse requires 
repetitive problems, that diagnosis couldn’t be 
made. Similarly, a patient might report one or two 
symptoms of alcohol dependence, but three are 
needed to qualify for a diagnosis. 
Any symptom of abuse or dependence is a cause for 
concern and should be addressed, since an alcohol 
use disorder may be present or developing. These 
patients may be more successful with abstaining as 
opposed to cutting down to recommended limits. 
Closer followup is indicated, as well as 
reconsidering the diagnosis as more information 
becomes available. 
Should I recommend any particular behavioral 
therapy for patients with alcohol use disorders? 
Several types of behavioral therapy are used to 
treat alcohol use disorders. Cognitive-behavioral 
therapy, motivational enhancement, and 12-step 
facilitation (e.g., the Minnesota Model) have all 
been shown to be effective.36 A combination of 
approaches has been shown to be effective as well 
(see the next question). Getting help in itself 
appears to be more important than the particular 
approach used, provided it avoids heavy con­
frontation and incorporates the basic elements of 
empathy, motivational support, and an explicit 
focus on changing drinking behavior. For patients 
receiving medications for alcohol dependence, brief 
medical counseling sessions delivered by a nurse or 
physician have been shown to be effective without 
additional behavioral treatment by a specialist22 
(see page 17). 
In addition to more formal treatment approaches, 
mutual help groups such as Alcoholics Anonymous 
(AA) appear to be very beneficial for people who 
stick with them. AA is widely available, free, and 
requires no commitment other than a desire to 
stop drinking. If you’ve never attended a meeting, 
consider doing so as an observer and supporter. 
To learn more, visit www.aa.org. Other self-help 
organizations that offer secular approaches, groups 
for women only, or support for family members 
can be found on the National Clearinghouse for 
Alcohol and Drug Information Web site 
(www.ncadi.samhsa.gov) under “Resources.”  
As a mental health clinician, how can I learn 
more about specialized alcohol counseling? 
For a recent major clinical trial, NIAAA grantees 
designed state-of-the-art individual outpatient 
psychotherapy for alcohol dependence. Called 
a combined behavioral intervention (CBI), 
it integrates cognitive-behavioral therapy, 
motivational enhancement, 12-step approaches, 
couples therapy, and community reinforcement— 
all treatments shown in earlier studies to be 
beneficial. Behavioral specialists deliver CBI in up 
to 20 sessions of 50 minutes (the median in the 
trial was 10 sessions). The treatment has four 
phases: building motivation for change, developing 
an individual plan for treatment and change, 
completing individualized skill-training modules, 
and performing maintenance checkups. Findings 
from the trial show that this specialized alcohol 
counseling or the medication naltrexone was 
effective, when coupled with structured medical 
management.22 The CBI strategy and supporting 
materials are provided in the 328-page Combined 
Behavioral Intervention Manual from Project 
COMBINE; to order for a small fee, visit 
www.niaaa.nih.gov/guide. 
How should alcohol withdrawal be managed? 
Alcohol withdrawal results when a person who 
is alcohol dependent suddenly stops drinking. 
Symptoms usually start within a few hours and 
consist of tremors, sweating, elevated pulse and 
blood pressure, nausea, insomnia, and anxiety. 
Generalized seizures may also occur. A second 
syndrome, alcohol withdrawal delirium, sometimes 
follows. Beginning after 1 to 3 days and lasting 
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2 to 10 days, it consists of an altered sensorium, 
disorientation, poor short-term memory, altered 
sleep-wake cycle, and hallucinations. Management 
typically consists of administering thiamine and 
benzodiazepines, sometimes together with 
anticonvulsants, beta adrenergic blockers, or 
antipsychotics as indicated. Mild withdrawal can 
be managed successfully in the outpatient setting, 
but more complicated or severe cases require 
hospitalization. (Consult references 37 and 38 on 
page 34 for additional information.) 
Are laboratory tests available to screen for 
or monitor alcohol problems? 
For screening purposes in primary care settings, 
interviews and questionnaires have greater 
sensitivity and specificity than blood tests for 
biochemical markers, which identify only about 
10 to 30 percent of heavy drinkers.39,40 Nevertheless, 
biochemical markers may be useful when heavy 
drinking is suspected but the patient denies it. The 
most sensitive and widely available test for this 
purpose is the serum gamma-glutamyl transferase 
(GGT) assay. It isn’t very specific, however, so 
reasons for GGT elevation other than excessive 
alcohol use need to be eliminated. If elevated at 
baseline, GGT and other transaminases may also 
be helpful in monitoring progress and identifying 
relapse, and serial values can provide valuable 
feedback to patients after an intervention. Other 
blood tests include the mean corpuscular volume 
(MCV) of red blood cells, which is often elevated 
in people with alcohol dependence, and the 
carbohydrate-deficient transferrin (CDT) assay. 
The CDT assay is about as sensitive as the GGT 
and has the advantage of not being affected by 
liver disease.41 
If I refer a patient for alcohol treatment, what 
are the chances for recovery? 
A review of seven large studies of alcoholism 
treatment found that about one-third of patients 
either were abstinent or drank moderately without 
negative consequences or dependence in the year 
following treatment.42 Although the other two-
thirds had some periods of heavy drinking, on 
average they reduced consumption and alcohol-
related problems by more than half. These 
reductions appear to last at least 3 years.36 This 
substantial improvement in patients who do not 
attain complete abstinence or problem-free reduced 
drinking is often overlooked. These patients may 
require further treatment, and their chances of 
benefiting the next time don’t appear to be 
influenced significantly by having had prior 
treatments.42 As is true for other medical disorders, 
some patients have more severe forms of alcohol 
dependence that may require long-term 
management. 
What can I do to help patients who struggle to 
remain abstinent or who relapse?  
Changing drinking behavior is a challenge, 
especially for those who are alcohol dependent. 
The first 12 months of abstinence are especially 
difficult, and relapse is most common during this 
time. If patients do relapse, recognize that they 
have a chronic disorder that requires continuing 
care, just like asthma, hypertension, or diabetes. 
Recurrence of symptoms is common and similar 
across each of these disorders,43 perhaps because 
they require the patient to change health behaviors 
to maintain gains. The most important principle is 
to stay engaged with the patient and to maintain 
optimism about eventual improvement. Most 
people with alcohol dependence who continue to 
work at recovery eventually achieve partial to full 
remission of symptoms, and often do so without 
specialized behavioral treatment.
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For patients who 
struggle to abstain or who relapse: 
• If the patient is not taking medication for 
alcohol dependence, consider prescribing one 
and following up with medication management 
(see pages 13–22). 
• Treat depression or anxiety disorders if they are 
present more than 2 to 4 weeks after abstinence 
is established. 
• Assess and address other possible triggers for 
struggle or relapse, including stressful events, 
interpersonal conflict, insomnia, chronic pain, 
craving, or high-temptation situations such as a 
wedding or convention. 
• If the patient is not attending a mutual help 
group or is not receiving behavioral therapy, 
consider recommending these support measures. 
• Encourage those who have relapsed by noting 
that relapse is common and pointing out the 
value of the recovery that was achieved. 
• Provide followup care and advise patients to 
contact you if they are concerned about relapse. 
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